...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, Synthesis, and Structure?Activity Relationship Studies of Novel Thioether Pleuromutilin Derivatives as Potent Antibacterial Agents
【24h】

Design, Synthesis, and Structure?Activity Relationship Studies of Novel Thioether Pleuromutilin Derivatives as Potent Antibacterial Agents

机译:新型硫醚截短侧耳素衍生物作为有效抗菌剂的设计,合成和结构-活性关系研究

获取原文
获取原文并翻译 | 示例

摘要

A series of novel thioether pleuromutilin derivatives incorporating various heteroaromatic substituents into the C14 side chain have been reported. Structure?activity relationship (SAR) studies resulted in compounds 52 and 55 with the most potent in vitro antibacterial activity among the series (MIC = 0.031?0.063 μg/mL). Further optimization to overcome the poor water solubility of compound 55 resulted in compounds 87, 91, 109, and 110 possessing good in vitro antibacterial activity with increased hydrophilicity. Compound 114, the water-soluble phosphate prodrug of compound 52, was also prepared and evaluated. Among the derivatives, compound 110 showed moderate pharmacokinetic profiles and good in vivo efficacy in both MSSA and MRSA systemic infection models. Compound 110 was further evaluated in CYP450 inhibition assay and displayed intermediate in vitro inhibition of CYP3A4.
机译:已经报道了一系列新的硫醚截短侧耳素衍生物,它们将各种杂芳族取代基并入C14侧链。结构活性关系(SAR)研究结果显示,化合物52和55在系列中的体外抗菌活性最高(MIC = 0.031-0.063μg/ mL)。克服化合物55不良的水溶性的进一步优化导致化合物87、91、109和110具有良好的体外抗菌活性,并增加了亲水性。还制备并评价了化合物114,即化合物52的水溶性磷酸盐前药。在衍生物中,化合物110在MSSA和MRSA全身感染模型中均显示出中等的药代动力学特征和良好的体内功效。在CYP450抑制试验中进一步评估了化合物110,并显示出对CYP3A4的体外体外抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号